RETA שווי כולל של נכסי החברה Reata Pharmaceuticals Inc

Reata Pharmaceuticals (RETA) relies on external contractors for the development and release of medications to combat rare brain pathologies. Simultaneously, the company is implementing "green" standards in its laboratories to minimize environmental impact. Total assets amount to 567.12, which is supported by the stable operation of sterile facilities. This chart of current stock quotes on GURU.Markets clearly demonstrates the financial condition of this business.

For the biopharmaceutical company Reata Pharmaceuticals (RETA), whose model is based on the global scaling of proprietary drugs, an analysis of total assets (via ROA) reveals the real value of resources derived through a reverse profitability calculation. This metric aggregates equity and liabilities, allowing investors to identify risks of excessive leverage that could offset high drug production margins and lead to a severe business write-down.